Discovery may aid autoimmune
treatment
ANN ARBOR, Mich., -- University of Michigan
scientists say a new discovery could help scientists
understand what causes autoimmune diseases like rheumatoid
arthritis. In a study published online in Nature,
researchers from the university's medical school found
that the protein cryopyrin responds to invading bacteria
by triggering the activation of a powerful inflammatory
molecule called IL-1beta, which signals the immune system
to attack pathogens and induces fever to pro- tect the
body against infection. Found in the fluid inside cells,
cryopyrin is a member of the NOD-LRR family of pro- teins,
which protect cells against microbial infection. Defective
cryopyrin is associated with increased suscept- ibility to
infection. Small mutations in CIAS1 --the human gene for
cryopyrin-- are known to cause three rare auto-
inflammatory diseases: familial cold autoinflammatory syn-
drome, Muckle-Wells syndrome and neonatal-onset multiple-
system inflammatory disease. The scientists found that
activated cryopyrin triggers a enzyme called caspase-1,
which splits the immature form of IL-1beta to produce the
active form of the molecule. Once IL-1beta is activated,
it can be secreted out of the cell where it binds to the
IL-1beta receptor on other cells to trigger an immune
response.
|
|